Literature DB >> 21762013

Fok-I polymorphism of vitamin D receptor gene and the presence of renal dysfunction in patients with β-thalassemia major.

Meropi Dimitriadou1, Athanasios Christoforidis, Marina Economou, Aikaterini Teli, Nikoleta Printza, Vasiliki Tzimouli, Ioanna Tsatra, Liana Fidani, Fotis Papachristou, Miranda Athanassiou-Metaxa.   

Abstract

Recent evidence supports the presence of renal dysfunction even among young patients with β-thalassemia major. However, the possible genetic contribution has never been investigated. The aim of this study was to correlate the presence of Fok-I polymorphism of the vitamin D receptor gene with abnormal levels of early markers of renal impairment in children and young adults with thalassemia. Thirty-four patients (19 male and 15 female) with β-thalassemia major on conventional treatment, with a mean decimal age of 14.62 ± 5.47 years (range: 5-22 years), were included in the study. Markers of renal function were determined in serum and in urine and patients were genotyped for Fok-I gene polymorphism. Genotype frequencies were similar to those previously reported for other populations: 47.06% of the patients were homozygous for the F allele, 41.18% were heterozygous, and 11.76% were homozygous for the f allele. A considerable number of patients demonstrated impaired renal function with increased serum cystatin C levels (29.41%), glomerular dysfunction with proteinuria (68%), as well as significant tubulopathy with hypercalciuria (73.08%), and increased levels of urinary β(2)-microglobulin (29.41%). When patients were stratified according to Fok-I polymorphism, a significantly higher prevalence of abnormally increased serum levels of cystatin C was observed in patients being homozygous for the f allele (75%) compared with those being heterozygous (Ff) or homozygous for the F allele (14.29% and 31.25%, respectively, P = .02). Further studies are needed to confirm these preliminary results and elucidate the possible mechanisms involved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21762013     DOI: 10.3109/08880018.2011.579231

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  3 in total

1.  Vitamin D Receptor (VDR) Gene Polymorphisms (FokI, BsmI) and their Relation to Vitamin D Status in Pediatrics βeta Thalassemia Major.

Authors:  Shereen Mohamed Elhoseiny; Dalia Saber Morgan; Asmaa Mohamed Rabie; Samer Tharwat Bishay
Journal:  Indian J Hematol Blood Transfus       Date:  2015-05-19       Impact factor: 0.900

2.  Interactions between serum vitamin D levels and vitamin D receptor gene FokI polymorphisms for renal function in patients with type 2 diabetes.

Authors:  Keitaro Yokoyama; Akio Nakashima; Mitsuyoshi Urashima; Hiroaki Suga; Takeshi Mimura; Yasuo Kimura; Yasushi Kanazawa; Tamotsu Yokota; Masaya Sakamoto; Sho Ishizawa; Rimei Nishimura; Hideaki Kurata; Yudo Tanno; Katsuyoshi Tojo; Shigeru Kageyama; Ichiro Ohkido; Kazunori Utsunomiya; Tatsuo Hosoya
Journal:  PLoS One       Date:  2012-12-04       Impact factor: 3.240

3.  Genetic Variation Impacts in Patients with Major Beta-Thalassemia.

Authors:  Maliheh Najaf Pour; Majid Farshdousti Hagh; Ali Akbar Movasagpoor Akbari; Abbas Ali Hosein Poor Feyzi; Majid Malaki
Journal:  Iran J Public Health       Date:  2015-05       Impact factor: 1.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.